VIP 5MG – Research-Use-Only Vasoactive Intestinal Peptide
The VIP 5MG product provides a purified form of vasoactive intestinal peptide (VIP) for academic and industrial research applications. VIP is a neuropeptide involved in numerous physiological processes, including gastrointestinal motility, neuroendocrine signaling, and immune regulation.
Research Context
Vasoactive intestinal peptide (VIP) is a 28-amino acid neuropeptide originally isolated from the gastrointestinal tract of mammals. Its discovery in the 1970s marked significant progress in understanding its roles in autonomic functions, including smooth muscle relaxation, endocrine cell stimulation, and modulation of inflammatory responses. Due to its broad biochemical activity, VIP remains a critical research tool for exploring neurobiological, immunological, and cardiovascular mechanisms.
Research Overview
VIP plays a central role in the regulation of gastrointestinal (GI) physiology, where it enhances intestinal fluid secretion, accelerates gastric emptying, and modulates peristalsis. Beyond GI functions, VIP is expressed in the central nervous system (CNS) and peripheral endocrine tissues, influencing neurotransmission, circadian rhythms, and stress responses. Research involving VIP is often conducted to investigate its potential as a biomarker or therapeutic target for conditions such as chronic diarrhea, neuroendocrine tumors, and inflammatory diseases.
Key Research Focus Areas
- Gastrointestinal Physiology: Investigation of VIP’s role in GI motility, fluid balance, and secretion in pre-clinical and in vitro models.
- Neuroendocrine Signaling: Study of VIP’s interactions with adrenergic and cholinergic pathways in the CNS, including its effects on appetite regulation and stress-related behaviors.
- Inflammatory and Immunological Mechanisms: Analysis of VIP’s anti-inflammatory properties, particularly in models of colitis, autoimmune diseases, and immune cell activation.
- Cardiovascular and Metabolic Research: Exploration of VIP’s impact on blood pressure regulation, insulin sensitivity, and metabolic homeostasis.
- Neurological Disorders: Examination of VIP’s potential as a biomarker or therapeutic target in conditions such as depression, anxiety, and neurodegenerative diseases.
Important Compliance and Safety Notice
This product is intended solely for academic research, scientific investigation, and industrial development purposes. It is not for human or animal consumption and should not be used in any therapeutic, diagnostic, or cosmetic capacity. Users must adhere to all applicable local, national, and international regulations governing research materials. Proper handling, storage, and documentation are required. For research use only. Not for human or animal consumption.





Reviews
There are no reviews yet.